General Information of Drug (ID: DMF9RB4)

Drug Name
Procysteine
Synonyms
Procysteine; 19771-63-2; (R)-2-Oxothiazolidine-4-carboxylic acid; (4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid; L-2-Oxothiazolidine-4-carboxylic acid; L-2-Oxothiazolidine-4-carboxylate; 4-Thiazolidinecarboxylic acid, 2-oxo-, (4R)-; CCRIS 7672; Oxothiazolidine carboxylate, L-; UNII-X7063P804E; 2-Oxothiazolidine-4-carboxylate, L-; L-2-Oxo-4-thiazolidinecarboxylic acid; BRN 4179169; (R)-2-Oxo-4-thiazolidinecarboxylic acid; (4R)-2-oxo-4-thiazolidinecarboxylic acid; CHEMBL442218; 4-Thiazolidinecarboxylic acid, 2-oxo-, L-
Indication
Disease Entry ICD 11 Status REF
Amyotrophic lateral sclerosis 8B60.0 Phase 2 [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 147.15
Logarithm of the Partition Coefficient (xlogp) -0.1
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 4
Chemical Identifiers
Formula
C4H5NO3S
IUPAC Name
(4R)-2-oxo-1,3-thiazolidine-4-carboxylic acid
Canonical SMILES
C1[C@H](NC(=O)S1)C(=O)O
InChI
InChI=1S/C4H5NO3S/c6-3(7)2-1-9-4(8)5-2/h2H,1H2,(H,5,8)(H,6,7)/t2-/m0/s1
InChIKey
BMLMGCPTLHPWPY-REOHCLBHSA-N
Cross-matching ID
PubChem CID
72390
ChEBI ID
CHEBI:125673
CAS Number
19771-63-2
DrugBank ID
DB12224
TTD ID
D0M0UT
VARIDT ID
DR00913
INTEDE ID
DR1919

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Reactive oxygen species (ROS) TTULV0X NOUNIPROTAC Modulator [2]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Pyroglutamase (OPLAH)
Main DME
DEJ1LMB OPLA_HUMAN Substrate [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
Methylated-DNA--protein-cysteine methyltransferase (MGMT) OT40A9WH MGMT_HUMAN Gene/Protein Processing [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00002114) A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides. U.S. National Institutes of Health.
2 Protective effect of procysteine on Acinetobacter pneumonia in hyperoxic conditions. J Antimicrob Chemother. 2013 Oct;68(10):2305-10.
3 Increased expression of the MGMT repair protein mediated by cysteine prodrugs and chemopreventative natural products in human lymphocytes and tumor cell lines. Carcinogenesis. 2007 Feb;28(2):378-89.